Moxifloxacin Injection 400 mg/250 mL Suppliers & Bulk Manufacturers
Available Forms: IV Infusion
Available Strengths: 400 mg/250 mL
Reference Brands: Avelox®, Avalox®(EU); Avelox®(US)
Category: Respiratory Disorder
Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used for respiratory, sinus, and skin infections. Available in the US and EU as 400 mg tablets, IV infusion, and 0.5% eye drops, it's sold under brands like Avelox® and Vigamox®. Ideal for B2B, PCD, and global pharma markets.
Manufacture or export Moxifloxacin Injection? List it or send an offer →
Product Description:
Moxifloxacin is a fourth-generation fluoroquinolone antibiotic used to treat respiratory tract infections, sinusitis, skin infections, and intra-abdominal infections. It is available in the US and EU in multiple forms including 400 mg tablets, 400 mg/250 mL IV infusion, and 0.5% ophthalmic solution. Marketed under brand names such as Avelox®, Avalox®, and Vigamox®, Moxifloxacin is known for its once-daily dosing, excellent tissue penetration, and broad-spectrum antibacterial activity. Widely prescribed for both inpatient and outpatient care, it is a top product for B2B pharma, PCD franchise, and international export, serving as a critical antibiotic in global healthcare supply chains.
Moxifloxacin Injection — third party manufacturing & bulk supply
Moxifloxacin Injection 400 mg/250 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Moxifloxacin Injection is supplied as IV Infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Moxifloxacin Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Moxifloxacin Injection →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Moxifloxacin Injection is a broad-spectrum antibiotic given by intravenous infusion to treat serious bacterial infections. It is commonly used for community-acquired pneumonia, complicated skin and intra-abdominal infections, acute bacterial sinusitis and bronchitis, and in some cases for other severe bacterial infections under medical supervision. The injection is typically administered once daily under a healthcare provider’s care.
Moxifloxacin Injection contains the active ingredient moxifloxacin hydrochloride, a fluoroquinolone antibiotic that inhibits bacterial DNA replication, leading to bacterial cell death. The solution also includes non-medicinal ingredients such as buffering agents and water for injection.
A common trade name for the injectable form is Avelox I.V., though multiple generic versions and other brand names exist in different markets.
The original brand Avelox I.V. Moxam Injection in India. Other manufacturers, including some in India, also make it. Tell us your market and we will match you with suitable licensed makers.
The generic name is moxifloxacin hydrochloride for injection.
A well-known brand for the intravenous form is Avelox I.V., along with other regional brands.
It is manufactured in Germany (Bayer), India, USA, and other countries depending on the brand and local regulations.
Related Products
Moxifloxacin Drop
Strength:
0.5% (5 mg/mL)
Form: Opthalmic solution
Reference Brands: Vigamox®(US/LATAM)
View Details
Levofloxacin Infusion
Strength:
250 mg/50 mL, 500 mg/100 mL, 750 mg/150 mL
Form: IV Infusion
Reference Brands: Levaquin(US & EU), Tavanic(EU)
View Details
Chlorpheniramine Maleate
Strength:
Tab: 4 mg, 8 mg, 12 mg; Syrup: 2 mg/5 mL; Susp: 2 mg/mL
Form: Tablets, Syrup and Oral Suspension
Reference Brands: Chlor-Trimeton®(US), Piriton®(EU)
View Details
Cefpodoxime Proxetil
Strength:
Tab: 100 mg. 200 mg, Susp: 50 mg/5 mL, 100 mg/5 mL
Form: Tablets & oral suspension
Reference Brands: Vantin® (US)
View Details
Beractant
Strength:
25 mg/mL (100 mg/4 mL, 200 mg/8 mL vials)
Form: Intratracheal suspension
Reference Brands: Survanta(US & EU)
View Details
Acetylcysteine Oral Solution
Strength:
10% (100 mg/mL), 20% (200 mg/mL)
Form: Oral Solution
Reference Brands: Mucomyst(US); Fluimucil(EU)
View Details
Poractant Alfa
Strength:
80 mg/mL (120 mg/1.5 mL, 240 mg/3 mL vials)
Form: Intratracheal suspension
Reference Brands: Curosurf(Eu & US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit
